tirzepatide vs semaglutide weight loss safety Tirzepatide, which is better for you? tirzepatide #semaglutide #obesity #type2diabetes #cardiovascularcomplications
Description
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward based on therapeutic response and tolerability
Strategies to Minimize Injection Pain and Anxiety Warming the injection site with a warm compress for 3060 seconds before injecting enhances blood flow and can reduce the perception of needle entry
Tirzepatide Weight Loss Results Similar to semaglutide, tirzepatide users can expect to lose between 15 and 20% of their body weight depending on the maintenance dose
Pi-Sunyer X, Astrup A, Fujioka K, et al
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
The adaptation process partially resets with dose changes
